Streetbeat News

Revenues

IONS

Ionis Pharmaceuticals (NASDAQ:IONS) has received mixed analyst ratings, with a recent average price target of $61.08, reflecting a 10.89% increase from the previous target. Analysts have varied in their ratings, with some raising their price targets and others maintaining or lowering them. Ionis is a leader in antisense technology, with a focus on cardiovascular, metabolic, neurological, and rare diseases. Despite positive revenue growth, the company faces challenges with below-average ROE and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 4:00 pm

EQT

EQT Corporation (NYSE:EQT) has significantly outperformed the market over the past 20 years, achieving an average annual return of 17.11%. A $100 investment in EQT 20 years ago would be worth $2,367.52 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 4:00 pm

COST

Costco Wholesale (NASDAQ:COST) has significantly outperformed the market over the past 15 years, with an average annual return of 20.3%. A $1000 investment in Costco 15 years ago would now be worth $16,225, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 4:00 pm

ARGX

Analysts have varied ratings for argenx (NASDAQ:ARGX), with a mix of bullish and somewhat bullish sentiments. Recent analyst actions include several raised price targets, reflecting positive expectations. Argenx has shown strong revenue growth and profitability, but its ROE is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 4:00 pm

UNP

Union Pacific (NYSE:UNP) has significantly outperformed the market over the past 20 years, with an annualized return of 15.05%. A $1000 investment in UNP 20 years ago would be worth $16,408.61 today. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 3:30 pm

SSNC

SS&C Technologies Holdings (NASDAQ:SSNC) has outperformed the market over the past decade with an average annual return of 13.22%, resulting in a $1000 investment growing to $3,390.75. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 3:30 pm

XNCR

Xencor (NASDAQ:XNCR) has received mixed analyst ratings, with 4 analysts somewhat bullish over the last quarter. The average 12-month price target is $31.0, with a high of $34.00 and a low of $27.00. Recent actions include RBC Capital raising its target to $34.00 and JP Morgan lowering it to $27.00. Xencor's financials show a significant revenue decline and negative net margin, but strong debt management.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 3:01 pm

HON

Analysts have provided mixed ratings on Honeywell Intl (NASDAQ:HON) over the past quarter, with all five ratings being indifferent. The average 12-month price target is $214.6, slightly up from $214.25. Honeywell's financials show strong revenue growth and profitability, with a focus on expanding its installed base.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 3:01 pm

PLTR

Palantir Technologies (NYSE:PLTR) has been analyzed by 13 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target has increased by 17.31% to $29.62. Analysts have adjusted their ratings and price targets, reflecting their views on Palantir's market performance. The company has shown strong revenue growth and profitability, but faces challenges with its return on equity.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 3:00 pm

JNJ

The article provides an in-depth analysis of Johnson & Johnson (JNJ) compared to its competitors in the pharmaceuticals industry. JNJ shows potential undervaluation with low PE, PB, and PS ratios but underperforms in ROE, EBITDA, gross profit, and revenue growth. Its lower debt-to-equity ratio indicates a stronger financial position.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 3:00 pm